Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Julia G. Johnson is active.

Publication


Featured researches published by Julia G. Johnson.


Immunological Reviews | 1997

Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cells for the study of T-cell activation in vivo

Kathryn A. Pape; Elizabeth R. Kearney; Alexander Khoruts; Anna Mondino; Rebecca Merica; Zong Ming Chen; Elizabeth Ingulli; Jennifer A. White; Julia G. Johnson; Marc K. Jenkins

Summary: Adoptive transfer of TCR‐transgenic T cells uniformly expressing an identifiable TCR of known peptide/MHC specificity can be used to monitor the in vivo behavior of antigen‐specific T cells. We have used this system to show that naive T cells are initially activated within the T‐cell zones of secondary lymphoid tissue to prohferate in a B7‐dependent manner. If adjuvants or inflammatory cytokines are present during this period, enhanced numbers of T cells accumulate, migrate into B‐cell‐rich follicles, and acquire the capacity to produce IFN‐7 and help B cells produce IgG2a. If inflammation is absent, most of the initially activated antigen‐specific T cells disappear without entering the follicles and the survivors are poor producers of IL‐2 and IFN‐γ Our results indicate that inflammatory mediators play a key role in regulating the anatomic location, clonal expansion, survival and lymphokine production potential of antigen‐stimulated T cells in vivo.


Immunologic Research | 1993

Accessory cell-derived signals required for T cell activation

Julia G. Johnson; Marc K. Jenkins

Various populations of accessory cells differ in their abilities to function as effective antigen-presenting cells (APC) and stimulate CD4+ T cells to produce interleukin-2. Three important factors directly related to APC potency are the expression of class II major histocompatibility complex molecules and the ability to present peptide antigens to the T cell antigen receptor, the expression of costimulatory ligands which deliver important activation signals independent of T cell receptor occupancy and the expression of adhesion molecules which promote conjugate formation so that these activation signals can be effectively delivered to the T cells. The relative importance of these accessory cell functions in T cell activation will be discussed, with an emphasis on costimulation and the CD28/B7 receptor/ligand pair. The consequence of inadequate costimulation by an otherwise effective APC in inducting T cell anergy will also be discussed. *** DIRECT SUPPORT *** A02GS021 00006


Advances in Experimental Medicine and Biology | 1993

Costimulating Factors and Signals Relevant for Antigen Presenting Cell Function

Marc K. Jenkins; Dimuthu R. DeSilva; Julia G. Johnson; Steven D. Norton

The antigen-specific activation of CD4+ T lymphocytes is absolutely dependent on ligands expressed on the surface of specialized hematopoietic cells1 known as antigenpresenting cells (APC). Recent results from many laboratories suggest that these ligands include: major histocompatibility complex (MHC) -encoded class II molecules that are important for presenting antigenic peptides to the T cell antigen receptor (TCR); adhesion molecules that facilitate the formation of T cell/APC conjugates; and molecules that transduce nonspecific costimulatory signals upon binding their complementary T cell receptors1-3. The efficiency of various APC types in their capacity to stimulate T cells can therefore be influenced by qualitative and/or quantitative differences in the expression or function of any of these molecules. Here we describe our analysis of the contribution of antigen-presentation, adhesion, and costimulation to the functional APC potency of dendritic cells and B cells.


Science | 1998

Visualization of Specific B and T Lymphocyte Interactions in the Lymph Node

Paul Garside; Elizabeth Ingulli; Rebecca Merica; Julia G. Johnson; Randolph J. Noelle; Marc K. Jenkins


Current Opinion in Immunology | 1993

Molecules involved in T-cell costimulation.

Marc K. Jenkins; Julia G. Johnson


Journal of Immunology | 1999

Induction of Primary Human CD8+ T Lymphocyte Responses In Vitro Using Dendritic Cells

Angela L. Zarling; Julia G. Johnson; Robert W. Hoffman; David R. Lee


European Journal of Immunology | 1991

A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen‐presenting cells

Ronald Jemmerson; Julia G. Johnson; Edwin Burrell; P. Sean Taylor; Marc K. Jenkins


Journal of Immunology | 1994

Monocytes provide a novel costimulatory signal to T cells that is not mediated by the CD28/B7 interaction

Julia G. Johnson; Marc K. Jenkins


Life Sciences | 1994

Minireview The role of anergy in peripheral T cell unresponsiveness

Julia G. Johnson; Marc K. Jenkins


Journal of Investigative Dermatology | 1992

Co-Stimulatory Functions of Antigen-Presenting Cells

Julia G. Johnson; Marc K. Jenkins

Collaboration


Dive into the Julia G. Johnson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge